The case of niclosamide is relevant since it targets some relatively common gene fusions (or their associated chimeric proteins), aside from targeting relevant transcription factors such as CREB, STAT3 and NF-κB. Chromosomal aberrations and gene fusions in intimal sarcoma have also helped to identify potential therapeutic targets (169). This evidence concerns the gene CREB1 and intimal sarcoma.